Uncertainty surrounding potential US tariffs is threatening to disrupt India's booming pharma deal market, according to Rothschild & Co. While short-term M&A activity may slow due to a lack of ...

Organizations that invest in foresight and adaptability will not only weather the storm but also emerge stronger and better ...

Most companies facing Trump's tariff hits will seek better deals in countries hit with lower levies, since domestic sourcing remains too expensive, too long to start operations, and unable to meet ...